Identification and isolation of human corneal endothelial cells (hcecs)
AssigneeEmmetrope Ophtalmics LLC
InventorsJeffrey L. Goldberg, Noelia J. Zevitzky
Life of this patent
Estimating the term…
Loading patent…
AssigneeEmmetrope Ophtalmics LLC
InventorsJeffrey L. Goldberg, Noelia J. Zevitzky
Estimating the term…
The present invention provides methods for the identification, isolation and/or enrichment of human corneal endothelial cells (HCECs). In some embodiments, the method comprises a positive selection process in which a cell population containing human corneal cells is contacted with a positive affinity reagent that selectively binds to HCECs relative to cells other than HCECs (e.g., corneal keratocytes, etc.) in the population and/or a negative selection process in which a cell population containing HCECs is contacted with a negative affinity reagent that selectively binds to cells other than HCECs in the population relative to HCECs. The present invention also provides reagents and kits for the identification, isolation and/or enrichment of HCECs as well as compositions that are enriched in HCECs.
A method of forming a composition enriched with human corneal endothelial cells comprising:
2-3. (canceled)
5-8. (canceled)
(canceled)
12-13. (canceled)
15-16. (canceled)
(canceled)
A kit comprising (a) a positive affinity reagent that selectively binds to human corneal endothelial cells relative to cells other than human corneal endothelial cells and (b) a negative affinity reagent that selectively binds to cells other than human corneal endothelial cells relative to human corneal endothelial cells.
(canceled)
24-26. (canceled)
28-30. (canceled)
A composition enriched with human corneal endothelial cells comprising:
32-34. (canceled)
36-41. (canceled)
43-47. (canceled)
49-50. (canceled)
Dependencies are inferred from the claim text.